Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Literature
1.
Arola A et al (1998) Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 101(3 Pt 1):76–369
2.
Taliercio CP et al (1985) Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol 6(5):31–1126CrossRef
3.
Harmon WE et al (2005) Pediatric transplantation, 1994–2003. Am J Transplant 5(4 Pt 2):887–903PubMedCrossRef
4.
Shaddy RE et al (2007) Carvedilol for children and adolescents with heart failure––a randomized controlled trial. JAMA 298(10):1171–1179PubMedCrossRef
5.
Lewis AB (1999) Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy. Am Heart J 138(2 Pt 1):8–334
6.
Sliwa K et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12(8):78–767CrossRef
7.
Brookes CI et al (1995) Angiography and the aetiology of heart failure. Postgrad Med J 71(838):2–480CrossRef
8.
Cleland JG et al (2003) Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet 362(9377):14–21PubMedCrossRef
9.
Ghio S et al (2009) Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail 11(5):8–480CrossRef
10.
Bonnet D et al. Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure from ages 6 months to 18 years. ISRCTN 1186/ISRCTN60567801. Ongoing
Metadata
Title
The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy
Authors
Sunaina Parsons
Andrew L. Clark
John G. F. Cleland
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 10/2014
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-014-0731-1

Other articles of this Issue 10/2014

Clinical Research in Cardiology 10/2014 Go to the issue

Original Paper

Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: a case report and a systematic review

Letter to the Editors

Symptomatic arrhythmias due to syringomyelia-induced severe autonomic dysfunction

Original Paper

Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters

Review

Renal denervation: effects on atrial electrophysiology and arrhythmias

Original Paper

Prognostic impact of the serum heart-type fatty acid-binding protein (H-FABP) levels in patients admitted to the non-surgical intensive care unit

Original Paper

Heart rate recovery post 6-minute walking test in obstructive sleep apnea

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits